Feedback PLC – ICENI Centre & ISLCRS study to investigate whether textural features of rectal cancer on Magnetic Resonance can predict long term survival
Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long term survival in locally advanced rectal cancer patients. Omer Jalil, Asim Afaq, Balaji Ganeshan, Uday Patel, Raymond Endozo, Darren Boone, Ashley Groves, David Humber, Tan Arulampalam ICENI Centre Colchester University Hospital Colchester CO4 5JL Introduction: Heterogeneity is a well-known feature of malignancy and […]
Feedback PLC – Chief Scientific Officer Dr Balaji Ganeshan discusses latest developments on the ADVFN podcast
Feedback PLC – Chief Scientific Officer Dr Balaji Ganeshan discusses latest developments with Justin Waite on the ADVFN podcast. The interview with Balaji is 24 minutes in.
Feedback PLC – NHS England “Alert” on potential application of TexRAD for assessing lung cancer patients
Feedback plc is pleased to announce that the research arm of NHS England has published an “Alert” on the potential application of Feedback’s TexRAD CT texture analysis software for assessing patients with lung cancer. The National Institute for Health Research through its Horizon Scanning Research and Intelligence Centre (NIHR HSRIC) based at the University of […]
Feedback PLC forms JV with Quibim SL to develop Prostate Checker TexRAD application
Feedback plc is pleased to announce the incorporation of a 50:50 joint venture company, Prostate Checker Ltd, with QUIBIM S.L., to develop a specific application of TexRAD texture analysis in combination with multiple extracted parameters from MR images for the computer assisted detection and diagnosis of prostate cancer. To facilitate this, Feedback Plc has granted […]
Feedback PLC – Dr Balaji Ganeshan talks to DirectorsTalk about Stone Checker JV.
Dr Balaji Ganeshan, Chief Scientific Officer at Feedback (FDBK) talks to DirectorsTalk about a new JV with UKUA forming the company “Stone Checker Software Ltd”.
Feedback PLC announces it has licensed TexRAD to Stone Checker
Feedback plc (FDBK), the medical imaging software company, previously announced on 13 April 2015 that it had signed a research agreement with the Oxford Stone Group at the University of Oxford & Oxford University Hospital NHS Trust, UK to investigate the potential future clinical application of Feedback’s TexRAD texture analysis software on computed tomography (CT) […]
More Feedback please! Alan Green discusses Feedback (FDBK) developments on the ADVFN podcast
More Feedback please! Alan Green discusses Feedback (FDBK) developments with Justin Waite on the ADVFN podcast. FDBK assessment is 9 minutes in. Listen to the podcast here
Feedback (FDBK) – First sale of TexRAD in China
Feedback plc (FDBK), the medical imaging software company, is pleased to announce the first sale for research purposes of Feedback’s TexRAD texture analysis software in China. Peking Union Medical College Hospital, Beijing, China (‘PUMCH’), has recently purchased the TexRAD software to undertake research studies in cancer and other diseases. This has been made possible via […]
Feedback company TexRAD wins the inaugural Sussex Impact Award at the University of Sussex
Sussex research has improved lives and changed the outside world in areas from lad culture to chemical weapons and sustainable food, as recognised by an inaugural awards ceremony on campus on16 June. The winners of the first Sussex Impact and Research Awards were announced at a celebratory reception in the Jubilee building. Sussex researchers from across […]
Feedback PLC announces preliminary results from the Oxford Stone Group using TexRAD research software in the analysis of kidney stones
Feedback plc previously announced on 13 April 2015 that it had signed a research agreement with the Oxford Stone Group at the University of Oxford & Oxford University Hospital NHS Trust, UK to investigate the potential future clinical application of Feedback’s TexRAD texture analysis software on computed tomography (CT) image data of patients with kidney […]